Patent details

EP3251675 Title: PREVENTION OR TREATMENT OF URIC ACID OR GOUT DISEASE

Basic Information

Publication number:
EP3251675
PCT Application Number:
CN2016000061
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP167426329
PCT Publication Number:
WO2016119570
First applicant's nationality:
Translation Language:
EPO Publication Language:
English Title of Invention:
PREVENTION OR TREATMENT OF URIC ACID OR GOUT DISEASE
French Title of Invention:
PRÉVENTION OU TRAITEMENT DE MALADIE DE GOUTTE OU D'ACIDE URIQUE
German Title of Invention:
VORBEUGUNG ODER BEHANDLUNG VON HARNSÄURE- ODER GICHTERKRANKUNG
SPC Number:

Dates

Filing date:
28/01/2016
Grant date:
21/04/2021
EP Publication Date:
06/12/2017
PCT Publication Date:
04/08/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/04/2021
EP B1 Publication Date:
21/04/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
28/01/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/01/2026
 
 

Name:
SHANTON PHARMA PTE. LTD
Address:
168 Robinson Road, # 13-05 Capital Tower, 068912, Singapore , Singapore (SG)

History of Owners

From:
14/04/2021
To:
30/01/2026

Name:
Shanton Pharma Pte. Ltd.
Address:
80 Robinson Road 02-00, Singapore 068898, Singapore (SG)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
27/04/2021
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
ZHANG, Qian
Address:
China (CN)

2

Name:
CHI, Shuangshuang
Address:
China (CN)

3

Name:
LIU, Jinrong
Address:
China (CN)

4

Name:
HUANG, Zhenhua
Address:
China (CN)

Priority

1

Priority Number:
201510048096
Priority Date:
30/01/2015
Priority Country:
China (CN)

2

Priority Number:
201510080714
Priority Date:
13/02/2015
Priority Country:
China (CN)

3

Priority Number:
201510079809
Priority Date:
13/02/2015
Priority Country:
China (CN)

4

Priority Number:
201510216089
Priority Date:
30/04/2015
Priority Country:
China (CN)

Classification

IPC classification:
C07D 473/08; C07D 473/06; A61K 31/522; A61P 13/04; A61P 19/06; A61P 29/00; A61P 19/02; A61P 13/12;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2026/04
Publication date:
03/03/2026
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

Issue number:
202116
Publication date:
21/04/2021
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20260000049A
Date Registered:
30/01/2026
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Change of address
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
SHANTON PHARMA PTE. LTD
Address:
168 Robinson Road, # 13-05 Capital Tower, 068912, Singapore , Singapore (SG)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
01/02/2027
Annual Fee Number:
12
Annual Fee Amount:
165 Euro
Expected Payer:
Last Annual Fee Payment Date:
16/01/2026
Last Annual Fee Paid Number:
11
Last Annual Fee Paid Amount:
148 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
27/04/2021 Power Of Attorney 1
27/04/2021 Outgoing Correspondence 1
30/01/2026 Request For Change 1
02/02/2026 Outgoing Correspondence 1